Subarachnoid hemorrhage

Introduction

Subarachnoid hemorrhage (SAH) is bleeding into the space between the brain and the protective membranes (the subarachnoid space). It ranks among the most dramatic neurological emergencies, often striking suddenly with a thunderclap headache. Although SAH accounts for only about 5% of all strokes, its impact on daily life can be devastating—many survivors face lasting deficits, while mortality remains high. In this article we’ll walk through its symptoms, causes, diagnostic path, treatment options, prognosis, and what you can do to reduce risk.

Definition and Classification

Medically, subarachnoid hemorrhage is defined as bleeding into the subarachnoid space, which bathes the brain in cerebrospinal fluid. It’s clinically classified into:

• Aneurysmal SAH: The majority (about 85%) are due to ruptured cerebral aneurysms.
• Non‐aneurysmal perimesencephalic SAH: Bleeding localized around the brainstem without a clear aneurysm.
• Traumatic SAH: Following head injury—common in accidents.

Occasionally, rare causes like arteriovenous malformations, coagulopathy, or illicit drug use (e.g., cocaine) may underlie SAH. This condition affects the central nervous system, primarily the leptomeningeal vessels around the circle of Willis. Clinicians also grade SAH by severity (Hunt and Hess scale, WFNS grade) to guide management.

Causes and Risk Factors

Knowing what sets off an SAH can help in risk reduction. The main culprit is a ruptured berry aneurysm—small sac-like bulges in arterial walls—found in 2–5% of the population, though most never leak. Other causes include:

• Arteriovenous malformations (AVMs): Congenital vessel tangles that can bleed.
• Head trauma: Even mild trauma in elderly or on anticoagulants can trigger bleeding.
• Coagulopathies: Blood thinners (warfarin, direct oral anticoagulants), hemophilia.
• Vasculitis: Inflammatory disorders like lupus or polyarteritis nodosa.
• Substance use: Cocaine and amphetamines acutely elevate blood pressure, risking rupture.

Non-modifiable risks: family history of aneurysms (especially first-degree relative), certain genetic disorders (polycystic kidney disease, Ehlers–Danlos syndrome type IV), age (peak incidence 40–60 years), female sex (roughly a 1.6:1 ratio). Modifiable risks: hypertension, smoking (doubles risk), excessive alcohol intake. Despite extensive research, the precise triggers of aneurysm rupture remain incompletely understood.

Pathophysiology (Mechanisms of Disease)

Under normal conditions, cerebral vessels handle pulsatile blood flow without leaking. In SAH, vessel wall integrity is compromised—often by aneurysmal thinning—so that high arterial pressure bursts the sac. Blood then floods the subarachnoid space, irritating meninges and raising intracranial pressure. The cascade includes:

• Acute rise in intracranial pressure (ICP): Reduces cerebral perfusion, risking global ischemia.
• Cerebral vasospasm: Blood breakdown products (hemoglobin, oxyhemoglobin) trigger vessel constriction days later, leading to delayed ischemic deficits.
• Inflammatory response: Activation of microglia and cytokines contributes to edema and neuronal injury.
• Cerebrospinal fluid disturbance: Blood can obstruct CSF reabsorption, causing communicating hydrocephalus.

These mechanisms explain why SAH patients can worsen days after the initial bleed and why close monitoring in an ICU is crucial.

Symptoms and Clinical Presentation

SAH often presents suddenly. Classic features include:

• “Thunderclap” headache—instant, excruciating pain often described as the “worst headache of my life.”
• Nausea and vomiting, usually immediate.
• Neck stiffness and photophobia due to meningeal irritation.
• Altered mental status: confusion, drowsiness, or abrupt loss of consciousness.
• Focal neurological signs: cranial nerve palsies (e.g., third nerve palsy in posterior communicating artery aneurysm), hemiparesis.
• Seizures in up to 10–15% of cases on presentation.

Early warning leaks (“sentinel headaches”) occur in about 20–30% of patients days or weeks before major SAH—often misdiagnosed as migraine. Advanced signs: deep coma, decerebrate posturing if bleeding is massive. Variation is wide: some mild cases remain alert, whereas others collapse immediately.

Warning sign requiring urgent care: any sudden, severe headache like no other should prompt a 911 call or immediate ER visit.

Diagnosis and Medical Evaluation

Time is brain in SAH: rapid diagnosis guides life-saving treatment. The typical pathway:

• Noncontrast head CT scan: First-line—detects acute blood in >95% of cases within 24 hours. Look for hyperdensity in basal cisterns.
• CT angiography (CTA): Offers quick vascular mapping—identifies aneurysms in the same session, often before formal angiography.
• Digital subtraction angiography (DSA): Gold standard for detailed aneurysm anatomy—used preoperatively or if CTA is inconclusive.
• Lumbar puncture: If CT is negative but suspicion high—xanthochromia indicates blood breakdown products in CSF after ~12 hours.
• Additional tests: MRI/MRA in select cases, transcranial Doppler for vasospasm monitoring, ECG and troponin as SAH often triggers cardiac stress changes.

Differential diagnoses include migraine, meningitis, intracerebral hemorrhage, reversible cerebral vasoconstriction syndrome. A thorough neurological exam and imaging sequence help narrow the causes swiftly.

Which Doctor Should You See for Subarachnoid Hemorrhage?

If you suspect SAH, call emergency services immediately—this is not a telemedicine moment. In hospital, you’ll see a neurologist and often a neurosurgeon. For ongoing care:

• Neurologist: Diagnoses, coordinates imaging, manages vasospasm risk.
• Neurosurgeon or Interventional Neuroradiologist: Performs clipping or endovascular coiling of aneurysms.
• Intensive Care Specialist: Manages blood pressure, intracranial pressure, fluid balance.

After stabilization, rehabilitation medicine, physical therapy, and sometimes neuopsychology help with recovery. Online consultations can be helpful for second opinions: interpreting your angiogram report or clarifying why you’re on nimodipine for weeks afterward. But nothing replaces hands-on neuro exam if new deficits arise.

Treatment Options and Management

Evidence-based interventions focus on preventing re-bleeding and vasospasm:

• Aneurysm repair: Surgical clipping or endovascular coiling—choice depends on aneurysm size, location, patient anatomy.
• Blood pressure control: Keep systolic pressure below 160 mm Hg (some protocols target <140 mm Hg) to reduce re-bleeding risk.
• Nimodipine: A calcium channel blocker started within 96 hours—reduces delayed cerebral ischemia.
• Intracranial pressure management: External ventricular drain if hydrocephalus or refractory ICP elevation.
• Vasospasm therapy: Induced hypertension, hemodilution, hypervolemia (“triple-H therapy”), or endovascular spasmolysis.
• Supportive care: Seizure prophylaxis, DVT prevention, bowel and bladder care.

Rehabilitation begins early: physical, occupational, speech therapy as needed.

Prognosis and Possible Complications

Overall mortality for aneurysmal SAH is about 40–50%. Of survivors, roughly one-third make a good recovery, one-third have moderate disability, and one-third remain severely disabled. Key factors influencing outcome:

• Clinical grade on presentation (Hunt and Hess)
• Aging and comorbidities (e.g., hypertension, renal disease)
• Amount of blood on initial CT (Fisher grade)
• Timeliness of aneurysm securement

Major complications if untreated or poorly managed:

• Re-bleeding—highest risk in first 24 hours.
• Delayed cerebral ischemia from vasospasm (peak days 4–14).
• Hydrocephalus—acute or chronic needing shunt.
• Electrolyte disturbances (hyponatremia via SIADH or cerebral salt wasting).
• Seizures and neurocognitive deficits (memory, executive function).

Prevention and Risk Reduction

While you can’t predict every aneurysm, risk reduction strategies include:

• Blood pressure control: Aim for <140/90 mm Hg—home monitoring helps.
• Smoking cessation: Smoking doubles rupture risk—resources like quitlines matter.
• Limit alcohol: Binge drinking spikes blood pressure acutely.
• Screening: For high-risk individuals (≥2 first-degree relatives with aneurysms, polycystic kidney disease), MRA or CTA every 5–10 years.
• Healthy lifestyle: Balanced diet, regular exercise, stress management.

Note: Routine screening in low-risk people is not recommended—the yield is low and false positives can cause unnecessary anxiety or procedures.

Myths and Realities

Let’s bust some common myths:

• Myth: “A small aneurysm never ruptures.” Reality: Even aneurysms <5 mm can bleed, especially in the posterior circulation.
• Myth: “Only old people get SAH.” Reality: Though peak is 40–60 years, younger adults can suffer, especially if they use stimulants.
• Myth: “Head CT always shows SAH.” Reality: CT sensitivity drops below 90% after 72 hours—LP may be needed.
• Myth: “Clipping is always better than coiling.” Reality: Each has pros and cons—coil patients may need retreatment, while clipping is more invasive.
• Myth: “A thunderclap headache is just a bad migraine.” Reality: Never assume—urgent evaluation rules out SAH.

These misunderstandings can delay care and worsen outcomes—so get the facts straight.

Conclusion

Subarachnoid hemorrhage remains one of the most urgent neurosurgical conditions, with sudden onset and high stakes. Early recognition of “the worst headache of my life” by patients and clinicians, rapid imaging, and timely aneurysm repair are the pillars of better outcomes. Blood pressure control, nimodipine use, and vigilant ICU care help avoid deadly complications like re-bleeding and vasospasm. Survivors often face long rehab journeys—physical, cognitive, emotional—but many regain meaningful independence. If you or someone you know experiences a thunderclap headache or unexplained neck stiffness, don’t wait: seek medical attention immediately. A prompt diagnosis can literally save your life.

Frequently Asked Questions (FAQ)

• 1. What is a subarachnoid hemorrhage?
• Bleeding into the space between the brain and its protective membranes, often from a ruptured aneurysm.
• 2. What causes SAH?
• Most commonly a ruptured berry aneurysm; also trauma, AVMs, coagulopathy, vasculitis, or stimulant use.
• 3. Who is at risk?
• People with hypertension, smokers, first-degree relatives of aneurysm patients, certain genetic disorders.
• 4. What are SAH symptoms?
• Sudden severe (“thunderclap”) headache, nausea, neck stiffness, photophobia, altered consciousness.
• 5. How is SAH diagnosed?
• Noncontrast head CT first, followed by CTA or DSA; lumbar puncture if CT is inconclusive.
• 6. Can SAH be prevented?
• Control blood pressure, quit smoking, moderate alcohol, consider screening if high familial risk.
• 7. What treatments exist?
• Aneurysm clipping or coiling, nimodipine for vasospasm, blood pressure management, ICU monitoring.
• 8. What are complications?
• Re-bleeding, delayed vasospasm, hydrocephalus, seizures, hyponatremia, cognitive deficits.
• 9. What specialists treat SAH?
• Neurologists, neurosurgeons, interventional neuroradiologists, ICU doctors, rehab therapists.
• 10. Can telemedicine help?
• Yes—for second opinions, clarifying imaging reports, medication questions, but not in place of emergency care.
• 11. When should I go to the ER?
• Immediately if you have a sudden, worst-ever headache, neck stiffness, or drop in consciousness.
• 12. What’s the recovery like?
• Varies widely—from full recovery to permanent deficits; rehabilitation is key.
• 13. Is hydrocephalus common?
• It affects about 20–30% of SAH patients; may require a temporary drain or permanent shunt.
• 14. How long do I take nimodipine?
• Typically 21 days after aneurysm treatment to reduce delayed cerebral ischemia risk.
• 15. Can I return to normal activities?
• Many do after rehab, but you may need lifestyle adjustments and follow-up imaging to monitor for new aneurysms.